Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
R. Daniel Meyer, Bohdana Ratitch, Marcel Wolbers et al. · Statistics in Biopharmaceutical Research · 2020
–The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis methods, need for additional analyses, ability to meet objectives and overall trial interpretability.
Cited by 86 works. doi:10.1080/19466315.2020.1779122 Open-access PDF
Authors
- R. Daniel Meyer
- Bohdana Ratitch
- Marcel Wolbers
- Olga Marchenko
- Hui Quan
- David N.M. Wright
- Yue Shentu
- Stefan Englert
- Jyotirmoy Dey
- Thomas Liu
- Ming Zhou
- Norman R. Bohidar
- Peng-Liang Zhao
- Michael Hale
References
- Statistical Analysis With Missing Data
- Multiple Imputation for Nonresponse in Surveys
- Statistical Analysis with Missing Data
- Missing Data in Clinical Studies
- Time-dependent bias was common in survival analyses published in leading clinical journals
- Use of historical control data for assessing treatment effects in clinical trials
- Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation
- A general statistical principle for changing a design any time during the course of a trial
- Bootstrap inference when using multiple imputation
- Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models